{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:52:20Z","timestamp":1771653140219,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K16453"],"award-info":[{"award-number":["JP22K16453"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08806"],"award-info":[{"award-number":["JP21K08806"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08805"],"award-info":[{"award-number":["JP21K08805"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08718"],"award-info":[{"award-number":["JP21K08718"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00520-023-08206-3","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T14:02:32Z","timestamp":1701871352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Systemic inflammation adversely affects response to anamorelin in patients with pancreatic cancer"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6953-1801","authenticated-orcid":false,"given":"Masashi","family":"Tsunematsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Uwagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Onda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimitsu","family":"Okui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenei","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunta","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"8206_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y et al (2016) Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 17:519\u2013531. https:\/\/doi.org\/10.1016\/S1470-2045(15)00558-6","journal-title":"Lancet Oncol"},{"key":"8206_CR2","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","volume":"28","author":"D Currow","year":"2017","unstructured":"Currow D, Temel JS, Abernethy A, Milanowski J, Friend J, Fearon KC (2017) ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia. Ann Oncol 28:1949\u20131956. https:\/\/doi.org\/10.1093\/annonc\/mdx192","journal-title":"Ann Oncol"},{"key":"8206_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cncr.31128","volume":"124","author":"N Katakami","year":"2018","unstructured":"Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K et al (2018) Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer 124:606\u2013616. https:\/\/doi.org\/10.1002\/cncr.31128","journal-title":"Cancer"},{"key":"8206_CR4","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1002\/cncr.32406","volume":"125","author":"S Hamauchi","year":"2019","unstructured":"Hamauchi S, Furuse J, Takano T, Munemoto Y, Furuya K, Baba H et al (2019) A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia. Cancer 125:4294\u20134302. https:\/\/doi.org\/10.1002\/cncr.32406","journal-title":"Cancer"},{"key":"8206_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00520-023-07576-y","volume":"31","author":"N Iwai","year":"2023","unstructured":"Iwai N, Sakai H, Oka K, Sakagami J, Okuda T, Hattori C et al (2023) Predictors of response to anamorelin in gastrointestinal cancer patients with cachexia: a retrospective study. Support Care Cancer 31:115. https:\/\/doi.org\/10.1007\/s00520-023-07576-y","journal-title":"Support Care Cancer"},{"key":"8206_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495. https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7","journal-title":"Lancet Oncol"},{"key":"8206_CR7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00595-016-1308-6","volume":"46","author":"J Watanabe","year":"2016","unstructured":"Watanabe J, Otani S, Sakamoto T, Arai Y, Hanaki T, Amisaki M et al (2016) Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Surg Today 46:1258\u20131267. https:\/\/doi.org\/10.1007\/s00595-016-1308-6","journal-title":"Surg Today"},{"key":"8206_CR8","doi-asserted-by":"publisher","first-page":"18758","DOI":"10.1038\/s41598-020-75745-8","volume":"10","author":"N Iwai","year":"2020","unstructured":"Iwai N, Okuda T, Sakagami J, Harada T, Ohara T, Taniguchi M et al (2020) Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Sci Rep 10:18758. https:\/\/doi.org\/10.1038\/s41598-020-75745-8","journal-title":"Sci Rep"},{"key":"8206_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2018.03.008","volume":"481","author":"RJ Hu","year":"2018","unstructured":"Hu RJ, Ma JY, Hu G (2018) Lymphocyte-to-monocyte ratio in pancreatic cancer: prognostic significance and meta-analysis. Clin Chim Acta 481:142\u2013146. https:\/\/doi.org\/10.1016\/j.cca.2018.03.008","journal-title":"Clin Chim Acta"},{"key":"8206_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00595-015-1206-3","volume":"46","author":"S Asari","year":"2016","unstructured":"Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Ishida J et al (2016) Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Surg Today 46:583\u2013592. https:\/\/doi.org\/10.1007\/s00595-015-1206-3","journal-title":"Surg Today"},{"key":"8206_CR11","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41598-017-03153-6","volume":"7","author":"J Hang","year":"2017","unstructured":"Hang J, Xue P, Yang H, Li S, Chen D, Zhu L et al (2017) Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. Sci Rep 7:2993. https:\/\/doi.org\/10.1038\/s41598-017-03153-6","journal-title":"Sci Rep"},{"key":"8206_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1023\/a:1015614505929","volume":"11","author":"T Matsumoto","year":"2002","unstructured":"Matsumoto T, Ohashi Y, Morita S, Kobayashi K, Shibuya M, Yamaji Y et al (2002) CPT-11 lung cancer study groups west and east. the quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in japanese patients with advanced non-small-cell lung cancer. Qual Life Res 11:483\u2013493. https:\/\/doi.org\/10.1023\/a:1015614505929","journal-title":"Qual Life Res"},{"issue":"Suppl 1","key":"8206_CR13","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.ejphar.2011.07.007","volume":"668","author":"JM Argil\u00e9s","year":"2011","unstructured":"Argil\u00e9s JM, Busquets S, L\u00f3pez-Soriano FJ (2011) Anti-inflammatory therapies in cancer cachexia. Eur J Pharmacol 668(Suppl 1):S81-86. https:\/\/doi.org\/10.1016\/j.ejphar.2011.07.007","journal-title":"Eur J Pharmacol"},{"key":"8206_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/jcm7120502","volume":"7","author":"YC Hou","year":"2018","unstructured":"Hou YC, Wang CJ, Chao YJ, Chen HY, Wang HC, Tung HL et al (2018) Elevated serum interleukin-8 level correlates with cancer-related cachexia and sarcopenia: an indicator for pancreatic cancer outcomes. J Clin Med 7:502. https:\/\/doi.org\/10.3390\/jcm7120502","journal-title":"J Clin Med"},{"key":"8206_CR15","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1097\/MPA.0000000000001878","volume":"50","author":"G Colloca","year":"2021","unstructured":"Colloca G, Venturino A (2021) Peripheral blood cell variables related to systemic inflammation in patients with unresectable or metastatic pancreatic cancer: a systematic review and meta-analysis. Pancreas 50:1131\u20131136. https:\/\/doi.org\/10.1097\/MPA.0000000000001878","journal-title":"Pancreas"},{"key":"8206_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1245\/s10434-022-12464-6","volume":"30","author":"K Haruki","year":"2023","unstructured":"Haruki K, Taniai T, Yanagaki M, Furukawa K, Tsunematsu M, Onda S et al (2023) Sustained systemic inflammatory response predicts survival in patients with hepatocellular carcinoma after hepatic resection. Ann Surg Oncol 30:604\u2013613. https:\/\/doi.org\/10.1245\/s10434-022-12464-6","journal-title":"Ann Surg Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-08206-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T14:15:46Z","timestamp":1703168146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-08206-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8206"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-08206-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional Ethics Committee of The Jikei University School of Medicine [27\u2013177(8062)] and conforms to the provisions of the Declaration of Helsinki, as revised in Fortaleza, Brazil in October 2013.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients by the opt-out method.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"732"}}